Rashid et al. [14] studied 176 Pakistani breast and ovarian cancer patients selected on family history and on age of diagnosis and identified a total of 30 sequence variants and among them 23 deleterious mutations in BRCA1 and 7 mutations BRCA2 gene. This evidence concerns the gene BRCA2 and ovarian cancer.